Skip to main content
OpenTrials

Clinical trial condition

Recurrent Acute Myeloid Leukemia

Explore clinical trials studying Recurrent Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

79 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Acute Myeloid Leukemia trial results

Recruiting

Personalized NK Cell Therapy in CBT

NCT02727803

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts

NCT03816319

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • VCU Massey Comprehensive Cancer Center Richmond, Virginia, United States
View Trial Details
Recruiting

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

NCT07022678

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Valley Children's Hospital Madera, California, United States
  • Kaiser Permanente-Oakland Oakland, California, United States
  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center Denver, Colorado, United States
View all 28 locations
View Trial Details
Recruiting

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

NCT07012044

Conditions
Acute Myeloid Leukemia Post Cytotoxic Therapy, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • C S Mott Children's Hospital Ann Arbor, Michigan, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
View Trial Details
Recruiting

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT03874052

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
  • UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas, United States
View Trial Details

Related conditions